Clinical Trial

Controlled Hypotension and Renal Injury During Septoplasty

Completed
View on ClinicalTrials.gov →
Summary
This prospective randomized single-blind study investigated the effects of two different mean arterial pressure (MAP) targets during controlled hypotension on renal injury in patients undergoing septoplasty. Participants were randomized to a low MAP target group (50-57 mmHg) or a higher MAP target group (58-65 mmHg). Renal injury was assessed using plasma neutrophil gelatinase-associated lipocalin (NGAL) levels measured at baseline, 6 hours, and 24 hours postoperatively.
Trial Details
NCT Number NCT07662577
Lead Sponsor Fatih Sultan Mehmet Training and Research Hospital
Conditions Hypotension During Surgery, NGAL, Kidney Injury
Enrollment 110 participants
Start Date 2019-05-01
Primary Completion 2020-05-01 (estimated)
Study Completion 2020-08-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-23